He CC - Search Results

1

The role of RCAS1 as a biomarker in diagnosing CRC and monitoring tumor recurrence and metastasis.

Han SX, Wang J, Wang LJ, Jin GH, Ying X, He CC, Guo XJ, Zhang JY, Zhang Y, Zhu Q. Han SX, et al. Among authors: he cc. Tumour Biol. 2014 Jun;35(6):6149-57. doi: 10.1007/s13277-014-1814-3. Epub 2014 Mar 21. Tumour Biol. 2014. PMID: 24652591

2

Gαs protein expression is an independent predictor of recurrence in prostate cancer.

Wang L, Jin G, He C, Guo X, Zhou X, Li M, Ying X, Wang L, Wu H, Zhu Q. Wang L, et al. J Immunol Res. 2014;2014:301376. doi: 10.1155/2014/301376. Epub 2014 Mar 31. J Immunol Res. 2014. PMID: 24741584 Free PMC article.

3

The role of PAM4 in the management of pancreatic cancer: diagnosis, radioimmunodetection, and radioimmunotherapy.

Han S, Jin G, Wang L, Li M, He C, Guo X, Zhu Q. Han S, et al. J Immunol Res. 2014;2014:268479. doi: 10.1155/2014/268479. Epub 2014 Apr 10. J Immunol Res. 2014. PMID: 24818166 Free PMC article. Review.

4

Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma.

Han SX, Bai E, Jin GH, He CC, Guo XJ, Wang LJ, Li M, Ying X, Zhu Q. Han SX, et al. Among authors: he cc. J Immunol Res. 2014;2014:261365. doi: 10.1155/2014/261365. Epub 2014 Apr 22. J Immunol Res. 2014. PMID: 24860833 Free PMC article.

5

Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma.

Han SX, Wang JL, Guo XJ, He CC, Ying X, Ma JL, Zhang YY, Zhao Q, Zhu Q. Han SX, et al. Among authors: he cc. J Immunol Res. 2014;2014:262385. doi: 10.1155/2014/262385. Epub 2014 Apr 17. J Immunol Res. 2014. PMID: 24860834 Free PMC article.

6

The intensity of radiotherapy-elicited immune response is associated with esophageal cancer clearance.

Ma JL, Jin L, Li YD, He CC, Guo XJ, Liu R, Yang YY, Han SX. Ma JL, et al. Among authors: he cc. J Immunol Res. 2014;2014:794249. doi: 10.1155/2014/794249. Epub 2014 May 22. J Immunol Res. 2014. PMID: 24967419 Free PMC article.

7

Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma.

Ying X, Zhao Y, Wang JL, Zhou X, Zhao J, He CC, Guo XJ, Jin GH, Wang LJ, Zhu Q, Han SX. Ying X, et al. Among authors: he cc. Oncol Rep. 2014 Oct;32(4):1550-6. doi: 10.3892/or.2014.3367. Epub 2014 Jul 30. Oncol Rep. 2014. PMID: 25109745

8

MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.

Wang LJ, He CC, Sui X, Cai MJ, Zhou CY, Ma JL, Wu L, Wang H, Han SX, Zhu Q. Wang LJ, et al. Among authors: he cc. Oncotarget. 2015 Mar 20;6(8):5932-46. doi: 10.18632/oncotarget.3465. Oncotarget. 2015. PMID: 25803229 Free PMC article.

9

A novel NGR-conjugated peptide targets DNA damage responses for radiosensitization.

Ma J, Zhang D, Ying X, Zhao Y, He C, Zhu Q, Han S. Ma J, et al. Curr Cancer Drug Targets. 2015;15(6):533-41. doi: 10.2174/1568009615666150408114817. Curr Cancer Drug Targets. 2015. PMID: 25850444

10

Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.

Han SX, Zhou X, Sui X, He CC, Cai MJ, Ma JL, Zhang YY, Zhou CY, Ma CX, Varela-Ramirez A, Zhu Q. Han SX, et al. Among authors: he cc. Oncotarget. 2015 Aug 14;6(23):19907-17. doi: 10.18632/oncotarget.4529. Oncotarget. 2015. PMID: 26101916 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters